REGENXBIO Inc. (RGNX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    REGENXBIO Inc.

    NASDAQ: RGNX · Real-Time Price · USD
    9.38
    0.02 (0.21%)
    At close: Sep 26, 2025, 1:14 PM

    REGENXBIO Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 83.33M 90.24M 112.72M 470.35M
    Cost of Revenue
    		 33.57M 37.21M 54.55M 51.83M
    Gross Profit
    		 49.76M 53.03M 58.18M 418.51M
    Operating Income
    		 -233.35M -268.13M -262.88M 159.98M
    Interest Income
    		 174K 25K 342K 719K
    Pretax Income
    		 -227.1M -263.65M -280.4M 141.25M
    Net Income
    		 -227.1M -263.49M -280.32M 127.84M
    Selling & General & Admin
    		 76.62M 88.49M 85.28M 79.33M
    Research & Development
    		 208.52M 232.27M 242.45M 181.44M
    Other Expenses
    		 -2.03M 397K -6.68M -2.24M
    Operating Expenses
    		 285.14M 321.16M 321.06M 258.53M
    Interest Expense
    		 12.66M 6.86M 23.25M 26.28M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 318.71M 358.37M 375.6M 310.37M
    Income Tax Expense
    		 n/a -152K -84K 13.41M
    Shares Outstanding (Basic)
    		 49.51M 43.73M 43.15M 42.44M
    Shares Outstanding (Diluted)
    		 49.51M 43.73M 43.15M 43.91M
    EPS (Basic)
    		 -4.59 -6.02 -6.5 3.01
    EPS (Diluted)
    		 -4.59 -6.02 -6.5 2.91
    EBITDA
    		 -198.23M -239.46M -244.24M 169.54M
    EBIT
    		 -214.44M -256.78M -257.15M 159.98M
    Depreciation & Amortization
    		 16.21M 17.32M 12.91M 9.56M

    Add to Watchlist